Abstract | BACKGROUND: METHODS: RESULTS: Forty-five patients had serum procalcitonin measured (mean = 2.7 +/- 3.2 ng/mL, first and third quartiles were 0.3 and 3.3 ng/mL, respectively). Most (78%) patients had high procalcitonin levels. RAI was present in 34 (76%) patients. Patients with high procalcitonin were more likely to have RAI (odds ratio, 4.8; 95% confidence interval, 1.1 - 22.1). Receiver operator characteristic curve analysis showed that the best cut-off for detecting RAI was 1.0 ng/mL (sensitivity = 79% and specificity = 55%). High serum procalcitonin was not associated with 28 -day mortality (80% for normal procalcitonin and 77% for high procalcitonin, p = 0.61). CONCLUSIONS:
|
Authors | Hasan M Al-Dorzi, Asgar H Rishu, Hani M Tamim, Abdulrahman Aljumah, Waleed Al-Tamimi, Salim Baharoon, Tarek Al Dabbagh, Yaseen M Arabi |
Journal | Clinical laboratory
(Clin Lab)
Vol. 60
Issue 7
Pg. 1105-14
( 2014)
ISSN: 1433-6510 [Print] Germany |
PMID | 25134378
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CALCA protein, human
- Placebos
- Protein Precursors
- Calcitonin
- Calcitonin Gene-Related Peptide
- Hydrocortisone
|
Topics |
- Adrenal Insufficiency
(blood, complications)
- Adult
- Aged
- Calcitonin
(blood)
- Calcitonin Gene-Related Peptide
- Female
- Humans
- Hydrocortisone
(blood)
- Liver Cirrhosis
(blood, complications, therapy)
- Male
- Middle Aged
- Placebos
- Protein Precursors
(blood)
- Shock, Septic
(blood, complications, therapy)
- Treatment Outcome
|